Summary

The global Skin Substitutes from Biological Sources market size was US$ 2102 million in 2025 and is forecast to reach a readjusted size of US$ 4543 million by 2032 with a CAGR of 11.8% during the forecast period 2026-2032.
Biological skin consists of the outer epidermis and/or dermis (the layer of skin between the epidermis and subcutaneous tissue) embedded in an acellular matrix (supporting structure) to form a biological skin substitute. Products are made from a variety of sources, including human tissue (from patients or others), non-human tissue (bovine, porcine, horse), synthetic materials (man-made), or a combination of these materials.
In 2025, the North America Skin Substitutes from Biological Sources market was US$ million, while the Europe market stood at US$ million. North America accounted for % of the global market in 2025 and Europe for %. Europe’s share is expected to reach % by 2032, corresponding to a CAGR of % over the analysis period.
The global key players of Skin Substitutes from Biological Sources include Allergan (AbbVie), AlloSource, Organogenesis, BD, Smith & Nephew, Integra LifeSciences, Synthes (Johnson & Johnson), Axogen, Vericel Corporation, LifeNet Health, among others. In 2025, the top five players accounted for approximately % of global market revenue.
In terms of revenue, the top three players in North America accounted for about % of the market in 2025, while the top three in Europe held nearly %.
The global Skin Substitutes from Biological Sources market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2021-2032.
Market Segmentation
By Company:
Allergan (AbbVie)
AlloSource
Organogenesis
BD
Smith & Nephew
Integra LifeSciences
Synthes (Johnson & Johnson)
Axogen
Vericel Corporation
LifeNet Health
MTF Biologics
Arthrex
Wright Medical Group NV (Stryker)
Cook Biotech Incorporated
Aroa Biosurgery
Surgalign Holdings
Anika Therapeutics
Forticell Bioscience
MLM Biologics
Promethean LifeSciences
Segment by Type
Allogeneic Acellular Cells
Xenogeneic Cells
Allogeneic Cells
Autologous Cells
Segment by Application
Hospitals
Specialty Clinics
Wound Care Centers
By Region
Macro-Region
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Markets
North America
Europe
China
Japan
(Additional regions can be customized based on client needs.)
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term)
Chapter 2: Quantitative analysis of Skin Substitutes from Biological Sources market size and growth potential at global, regional, and country levels
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus)
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities
Chapter 6: Regional revenue breakdown by company, type, application and customer
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Skin Substitutes from Biological Sources value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets

ページTOPに戻る

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size and Growth by Type: 2021 vs 2025 vs 2032
1.2.2 Allogeneic Acellular Cells
1.2.3 Xenogeneic Cells
1.2.4 Allogeneic Cells
1.2.5 Autologous Cells
1.3 Market by Application
1.3.1 Global Market Share by Application: 2021 vs 2025 vs 2032
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Wound Care Centers
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Skin Substitutes from Biological Sources Market Perspective (2021-2032)
2.2 Global Market Size by Region: 2021 vs 2025 vs 2032
2.3 Global Skin Substitutes from Biological Sources Market Share by Revenue, by Region (2021-2026)
2.4 Global Skin Substitutes from Biological Sources Revenue Forecast by Region (2027-2032)
2.5 Major Regions and Emerging Markets Analysis
2.5.1 North America Skin Substitutes from Biological Sources Market Size and Prospective (2021-2032)
2.5.2 Europe Skin Substitutes from Biological Sources Market Size and Prospective (2021-2032)
2.5.3 China Skin Substitutes from Biological Sources Market Size and Prospective (2021-2032)
2.5.4 Japan Skin Substitutes from Biological Sources Market Size and Prospective (2021-2032)

3 Breakdown Data by Type
3.1 Global Skin Substitutes from Biological Sources Historical Market Size by Type (2021-2026)
3.2 Global Skin Substitutes from Biological Sources Forecasted Market Size by Type (2027-2032)
3.3 Representative Players for Different Types of Skin Substitutes from Biological Sources

4 Breakdown Data by Application
4.1 Global Skin Substitutes from Biological Sources Historical Market Size by Application (2021-2026)
4.2 Global Skin Substitutes from Biological Sources Forecasted Market Size by Application (2027-2032)
4.3 New Sources of Growth in Skin Substitutes from Biological Sources Applications

5 Competitive Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Skin Substitutes from Biological Sources Players by Revenue (2021-2026)
5.1.2 Global Skin Substitutes from Biological Sources Market Share by Revenue, by Players (2021-2026)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Skin Substitutes from Biological Sources Revenue
5.4 Global Skin Substitutes from Biological Sources Market Concentration Analysis
5.4.1 Global Skin Substitutes from Biological Sources Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Skin Substitutes from Biological Sources Revenue in 2025
5.5 Global Key Players of Skin Substitutes from Biological Sources Head Offices and Areas Served
5.6 Global Key Players of Skin Substitutes from Biological Sources, Product and Application
5.7 Global Key Players of Skin Substitutes from Biological Sources, Date of Entry into This Industry
5.8 Mergers & Acquisitions, Expansion Plans

6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Skin Substitutes from Biological Sources Revenue by Company (2021-2026)
6.1.2 North America Market Size by Type
6.1.2.1 North America Skin Substitutes from Biological Sources Market Size by Type (2021-2026)
6.1.2.2 North America Skin Substitutes from Biological Sources Market Share by Type (2021-2026)
6.1.3 North America Market Size by Application
6.1.3.1 North America Skin Substitutes from Biological Sources Market Size by Application (2021-2026)
6.1.3.2 North America Skin Substitutes from Biological Sources Market Share by Application (2021-2026)
6.1.4 North America Skin Substitutes from Biological Sources Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Skin Substitutes from Biological Sources Revenue by Company (2021-2026)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Skin Substitutes from Biological Sources Market Size by Type (2021-2026)
6.2.2.2 Europe Skin Substitutes from Biological Sources Market Share by Type (2021-2026)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Skin Substitutes from Biological Sources Market Size by Application (2021-2026)
6.2.3.2 Europe Skin Substitutes from Biological Sources Market Share by Application (2021-2026)
6.2.4 Europe Skin Substitutes from Biological Sources Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Skin Substitutes from Biological Sources Revenue by Company (2021-2026)
6.3.2 China Market Size by Type
6.3.2.1 China Skin Substitutes from Biological Sources Market Size by Type (2021-2026)
6.3.2.2 China Skin Substitutes from Biological Sources Market Share by Type (2021-2026)
6.3.3 China Market Size by Application
6.3.3.1 China Skin Substitutes from Biological Sources Market Size by Application (2021-2026)
6.3.3.2 China Skin Substitutes from Biological Sources Market Share by Application (2021-2026)
6.3.4 China Skin Substitutes from Biological Sources Major Customers
6.3.5 China Market Trends and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Skin Substitutes from Biological Sources Revenue by Company (2021-2026)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Skin Substitutes from Biological Sources Market Size by Type (2021-2026)
6.4.2.2 Japan Skin Substitutes from Biological Sources Market Share by Type (2021-2026)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Skin Substitutes from Biological Sources Market Size by Application (2021-2026)
6.4.3.2 Japan Skin Substitutes from Biological Sources Market Share by Application (2021-2026)
6.4.4 Japan Skin Substitutes from Biological Sources Major Customers
6.4.5 Japan Market Trends and Opportunities

7 Key Player Profiles
7.1 Allergan (AbbVie)
7.1.1 Allergan (AbbVie) Company Details
7.1.2 Allergan (AbbVie) Business Overview
7.1.3 Allergan (AbbVie) Skin Substitutes from Biological Sources Introduction
7.1.4 Allergan (AbbVie) Revenue in Skin Substitutes from Biological Sources Business (2021-2026)
7.1.5 Allergan (AbbVie) Recent Development
7.2 AlloSource
7.2.1 AlloSource Company Details
7.2.2 AlloSource Business Overview
7.2.3 AlloSource Skin Substitutes from Biological Sources Introduction
7.2.4 AlloSource Revenue in Skin Substitutes from Biological Sources Business (2021-2026)
7.2.5 AlloSource Recent Development
7.3 Organogenesis
7.3.1 Organogenesis Company Details
7.3.2 Organogenesis Business Overview
7.3.3 Organogenesis Skin Substitutes from Biological Sources Introduction
7.3.4 Organogenesis Revenue in Skin Substitutes from Biological Sources Business (2021-2026)
7.3.5 Organogenesis Recent Development
7.4 BD
7.4.1 BD Company Details
7.4.2 BD Business Overview
7.4.3 BD Skin Substitutes from Biological Sources Introduction
7.4.4 BD Revenue in Skin Substitutes from Biological Sources Business (2021-2026)
7.4.5 BD Recent Development
7.5 Smith & Nephew
7.5.1 Smith & Nephew Company Details
7.5.2 Smith & Nephew Business Overview
7.5.3 Smith & Nephew Skin Substitutes from Biological Sources Introduction
7.5.4 Smith & Nephew Revenue in Skin Substitutes from Biological Sources Business (2021-2026)
7.5.5 Smith & Nephew Recent Development
7.6 Integra LifeSciences
7.6.1 Integra LifeSciences Company Details
7.6.2 Integra LifeSciences Business Overview
7.6.3 Integra LifeSciences Skin Substitutes from Biological Sources Introduction
7.6.4 Integra LifeSciences Revenue in Skin Substitutes from Biological Sources Business (2021-2026)
7.6.5 Integra LifeSciences Recent Development
7.7 Synthes (Johnson & Johnson)
7.7.1 Synthes (Johnson & Johnson) Company Details
7.7.2 Synthes (Johnson & Johnson) Business Overview
7.7.3 Synthes (Johnson & Johnson) Skin Substitutes from Biological Sources Introduction
7.7.4 Synthes (Johnson & Johnson) Revenue in Skin Substitutes from Biological Sources Business (2021-2026)
7.7.5 Synthes (Johnson & Johnson) Recent Development
7.8 Axogen
7.8.1 Axogen Company Details
7.8.2 Axogen Business Overview
7.8.3 Axogen Skin Substitutes from Biological Sources Introduction
7.8.4 Axogen Revenue in Skin Substitutes from Biological Sources Business (2021-2026)
7.8.5 Axogen Recent Development
7.9 Vericel Corporation
7.9.1 Vericel Corporation Company Details
7.9.2 Vericel Corporation Business Overview
7.9.3 Vericel Corporation Skin Substitutes from Biological Sources Introduction
7.9.4 Vericel Corporation Revenue in Skin Substitutes from Biological Sources Business (2021-2026)
7.9.5 Vericel Corporation Recent Development
7.10 LifeNet Health
7.10.1 LifeNet Health Company Details
7.10.2 LifeNet Health Business Overview
7.10.3 LifeNet Health Skin Substitutes from Biological Sources Introduction
7.10.4 LifeNet Health Revenue in Skin Substitutes from Biological Sources Business (2021-2026)
7.10.5 LifeNet Health Recent Development
7.11 MTF Biologics
7.11.1 MTF Biologics Company Details
7.11.2 MTF Biologics Business Overview
7.11.3 MTF Biologics Skin Substitutes from Biological Sources Introduction
7.11.4 MTF Biologics Revenue in Skin Substitutes from Biological Sources Business (2021-2026)
7.11.5 MTF Biologics Recent Development
7.12 Arthrex
7.12.1 Arthrex Company Details
7.12.2 Arthrex Business Overview
7.12.3 Arthrex Skin Substitutes from Biological Sources Introduction
7.12.4 Arthrex Revenue in Skin Substitutes from Biological Sources Business (2021-2026)
7.12.5 Arthrex Recent Development
7.13 Wright Medical Group NV (Stryker)
7.13.1 Wright Medical Group NV (Stryker) Company Details
7.13.2 Wright Medical Group NV (Stryker) Business Overview
7.13.3 Wright Medical Group NV (Stryker) Skin Substitutes from Biological Sources Introduction
7.13.4 Wright Medical Group NV (Stryker) Revenue in Skin Substitutes from Biological Sources Business (2021-2026)
7.13.5 Wright Medical Group NV (Stryker) Recent Development
7.14 Cook Biotech Incorporated
7.14.1 Cook Biotech Incorporated Company Details
7.14.2 Cook Biotech Incorporated Business Overview
7.14.3 Cook Biotech Incorporated Skin Substitutes from Biological Sources Introduction
7.14.4 Cook Biotech Incorporated Revenue in Skin Substitutes from Biological Sources Business (2021-2026)
7.14.5 Cook Biotech Incorporated Recent Development
7.15 Aroa Biosurgery
7.15.1 Aroa Biosurgery Company Details
7.15.2 Aroa Biosurgery Business Overview
7.15.3 Aroa Biosurgery Skin Substitutes from Biological Sources Introduction
7.15.4 Aroa Biosurgery Revenue in Skin Substitutes from Biological Sources Business (2021-2026)
7.15.5 Aroa Biosurgery Recent Development
7.16 Surgalign Holdings
7.16.1 Surgalign Holdings Company Details
7.16.2 Surgalign Holdings Business Overview
7.16.3 Surgalign Holdings Skin Substitutes from Biological Sources Introduction
7.16.4 Surgalign Holdings Revenue in Skin Substitutes from Biological Sources Business (2021-2026)
7.16.5 Surgalign Holdings Recent Development
7.17 Anika Therapeutics
7.17.1 Anika Therapeutics Company Details
7.17.2 Anika Therapeutics Business Overview
7.17.3 Anika Therapeutics Skin Substitutes from Biological Sources Introduction
7.17.4 Anika Therapeutics Revenue in Skin Substitutes from Biological Sources Business (2021-2026)
7.17.5 Anika Therapeutics Recent Development
7.18 Forticell Bioscience
7.18.1 Forticell Bioscience Company Details
7.18.2 Forticell Bioscience Business Overview
7.18.3 Forticell Bioscience Skin Substitutes from Biological Sources Introduction
7.18.4 Forticell Bioscience Revenue in Skin Substitutes from Biological Sources Business (2021-2026)
7.18.5 Forticell Bioscience Recent Development
7.19 MLM Biologics
7.19.1 MLM Biologics Company Details
7.19.2 MLM Biologics Business Overview
7.19.3 MLM Biologics Skin Substitutes from Biological Sources Introduction
7.19.4 MLM Biologics Revenue in Skin Substitutes from Biological Sources Business (2021-2026)
7.19.5 MLM Biologics Recent Development
7.20 Promethean LifeSciences
7.20.1 Promethean LifeSciences Company Details
7.20.2 Promethean LifeSciences Business Overview
7.20.3 Promethean LifeSciences Skin Substitutes from Biological Sources Introduction
7.20.4 Promethean LifeSciences Revenue in Skin Substitutes from Biological Sources Business (2021-2026)
7.20.5 Promethean LifeSciences Recent Development

8 Skin Substitutes from Biological Sources Market Dynamics
8.1 Skin Substitutes from Biological Sources Industry Trends
8.2 Skin Substitutes from Biological Sources Market Drivers
8.3 Skin Substitutes from Biological Sources Market Challenges
8.4 Skin Substitutes from Biological Sources Market Restraints

9 Research Findings and Conclusion

10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Global Skin Substitutes from Biological Sources Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Global Skin Substitutes from Biological Sources Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 3. Global Market Skin Substitutes from Biological Sources Market Size (US$ Million) by Region:2021 vs 2025 vs 2032
Table 4. Global Skin Substitutes from Biological Sources Revenue (US$ Million) Market Share by Region (2021-2026)
Table 5. Global Skin Substitutes from Biological Sources Revenue Share by Region (2021-2026)
Table 6. Global Skin Substitutes from Biological Sources Revenue (US$ Million) Forecast by Region (2027-2032)
Table 7. Global Skin Substitutes from Biological Sources Revenue Share Forecast by Region (2027-2032)
Table 8. Global Skin Substitutes from Biological Sources Market Size by Type (2021-2026) & (US$ Million)
Table 9. Global Skin Substitutes from Biological Sources Market Share by Revenue, by Type (2021-2026)
Table 10. Global Skin Substitutes from Biological Sources Forecasted Market Size by Type (2027-2032) & (US$ Million)
Table 11. Global Skin Substitutes from Biological Sources Market Share by Revenue, by Type (2027-2032)
Table 12. Representative Players of Each Type
Table 13. Global Skin Substitutes from Biological Sources Market Size by Application (2021-2026) & (US$ Million)
Table 14. Global Skin Substitutes from Biological Sources Market Share by Revenue, by Application (2021-2026)
Table 15. Global Skin Substitutes from Biological Sources Forecasted Market Size by Application (2027-2032) & (US$ Million)
Table 16. Global Skin Substitutes from Biological Sources Market Share by Revenue, by Application (2027-2032)
Table 17. New Sources of Growth in Skin Substitutes from Biological Sources Applications
Table 18. Global Skin Substitutes from Biological Sources Revenue by Players (2021-2026) & (US$ Million)
Table 19. Global Skin Substitutes from Biological Sources Market Share by Players (2021-2026)
Table 20. Global Top Skin Substitutes from Biological Sources Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Skin Substitutes from Biological Sources as of 2025)
Table 21. Ranking of Global Top Skin Substitutes from Biological Sources Companies by Revenue (US$ Million) in 2025
Table 22. Global 5 Largest Players Market Share by Skin Substitutes from Biological Sources Revenue (CR5 and HHI) & (2021-2026)
Table 23. Global Key Players of Skin Substitutes from Biological Sources, Headquarters and Area Served
Table 24. Global Key Players of Skin Substitutes from Biological Sources, Product and Application
Table 25. Global Key Players of Skin Substitutes from Biological Sources, Date of Entry into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Skin Substitutes from Biological Sources Revenue by Company (2021-2026) & (US$ Million)
Table 28. North America Skin Substitutes from Biological Sources Market Share by Revenue, by Company (2021-2026)
Table 29. North America Skin Substitutes from Biological Sources Market Size by Type (2021-2026) & (US$ Million)
Table 30. North America Skin Substitutes from Biological Sources Market Size by Application (2021-2026) & (US$ Million)
Table 31. Europe Skin Substitutes from Biological Sources Revenue by Company (2021-2026) & (US$ Million)
Table 32. Europe Skin Substitutes from Biological Sources Market Share by Revenue, by Company (2021-2026)
Table 33. Europe Skin Substitutes from Biological Sources Market Size by Type (2021-2026) & (US$ Million)
Table 34. Europe Skin Substitutes from Biological Sources Market Size by Application (2021-2026) & (US$ Million)
Table 35. China Skin Substitutes from Biological Sources Revenue by Company (2021-2026) & (US$ Million)
Table 36. China Skin Substitutes from Biological Sources Market Share by Revenue, by Company (2021-2026)
Table 37. China Skin Substitutes from Biological Sources Market Size by Type (2021-2026) & (US$ Million)
Table 38. China Skin Substitutes from Biological Sources Market Size by Application (2021-2026) & (US$ Million)
Table 39. Japan Skin Substitutes from Biological Sources Revenue by Company (2021-2026) & (US$ Million)
Table 40. Japan Skin Substitutes from Biological Sources Market Share by Revenue, by Company (2021-2026)
Table 41. Japan Skin Substitutes from Biological Sources Market Size by Type (2021-2026) & (US$ Million)
Table 42. Japan Skin Substitutes from Biological Sources Market Size by Application (2021-2026) & (US$ Million)
Table 43. Allergan (AbbVie) Company Details
Table 44. Allergan (AbbVie) Business Overview
Table 45. Allergan (AbbVie) Skin Substitutes from Biological Sources Product
Table 46. Allergan (AbbVie) Revenue in Skin Substitutes from Biological Sources Business (2021-2026) & (US$ Million)
Table 47. Allergan (AbbVie) Recent Development
Table 48. AlloSource Company Details
Table 49. AlloSource Business Overview
Table 50. AlloSource Skin Substitutes from Biological Sources Product
Table 51. AlloSource Revenue in Skin Substitutes from Biological Sources Business (2021-2026) & (US$ Million)
Table 52. AlloSource Recent Development
Table 53. Organogenesis Company Details
Table 54. Organogenesis Business Overview
Table 55. Organogenesis Skin Substitutes from Biological Sources Product
Table 56. Organogenesis Revenue in Skin Substitutes from Biological Sources Business (2021-2026) & (US$ Million)
Table 57. Organogenesis Recent Development
Table 58. BD Company Details
Table 59. BD Business Overview
Table 60. BD Skin Substitutes from Biological Sources Product
Table 61. BD Revenue in Skin Substitutes from Biological Sources Business (2021-2026) & (US$ Million)
Table 62. BD Recent Development
Table 63. Smith & Nephew Company Details
Table 64. Smith & Nephew Business Overview
Table 65. Smith & Nephew Skin Substitutes from Biological Sources Product
Table 66. Smith & Nephew Revenue in Skin Substitutes from Biological Sources Business (2021-2026) & (US$ Million)
Table 67. Smith & Nephew Recent Development
Table 68. Integra LifeSciences Company Details
Table 69. Integra LifeSciences Business Overview
Table 70. Integra LifeSciences Skin Substitutes from Biological Sources Product
Table 71. Integra LifeSciences Revenue in Skin Substitutes from Biological Sources Business (2021-2026) & (US$ Million)
Table 72. Integra LifeSciences Recent Development
Table 73. Synthes (Johnson & Johnson) Company Details
Table 74. Synthes (Johnson & Johnson) Business Overview
Table 75. Synthes (Johnson & Johnson) Skin Substitutes from Biological Sources Product
Table 76. Synthes (Johnson & Johnson) Revenue in Skin Substitutes from Biological Sources Business (2021-2026) & (US$ Million)
Table 77. Synthes (Johnson & Johnson) Recent Development
Table 78. Axogen Company Details
Table 79. Axogen Business Overview
Table 80. Axogen Skin Substitutes from Biological Sources Product
Table 81. Axogen Revenue in Skin Substitutes from Biological Sources Business (2021-2026) & (US$ Million)
Table 82. Axogen Recent Development
Table 83. Vericel Corporation Company Details
Table 84. Vericel Corporation Business Overview
Table 85. Vericel Corporation Skin Substitutes from Biological Sources Product
Table 86. Vericel Corporation Revenue in Skin Substitutes from Biological Sources Business (2021-2026) & (US$ Million)
Table 87. Vericel Corporation Recent Development
Table 88. LifeNet Health Company Details
Table 89. LifeNet Health Business Overview
Table 90. LifeNet Health Skin Substitutes from Biological Sources Product
Table 91. LifeNet Health Revenue in Skin Substitutes from Biological Sources Business (2021-2026) & (US$ Million)
Table 92. LifeNet Health Recent Development
Table 93. MTF Biologics Company Details
Table 94. MTF Biologics Business Overview
Table 95. MTF Biologics Skin Substitutes from Biological Sources Product
Table 96. MTF Biologics Revenue in Skin Substitutes from Biological Sources Business (2021-2026) & (US$ Million)
Table 97. MTF Biologics Recent Development
Table 98. Arthrex Company Details
Table 99. Arthrex Business Overview
Table 100. Arthrex Skin Substitutes from Biological Sources Product
Table 101. Arthrex Revenue in Skin Substitutes from Biological Sources Business (2021-2026) & (US$ Million)
Table 102. Arthrex Recent Development
Table 103. Wright Medical Group NV (Stryker) Company Details
Table 104. Wright Medical Group NV (Stryker) Business Overview
Table 105. Wright Medical Group NV (Stryker) Skin Substitutes from Biological Sources Product
Table 106. Wright Medical Group NV (Stryker) Revenue in Skin Substitutes from Biological Sources Business (2021-2026) & (US$ Million)
Table 107. Wright Medical Group NV (Stryker) Recent Development
Table 108. Cook Biotech Incorporated Company Details
Table 109. Cook Biotech Incorporated Business Overview
Table 110. Cook Biotech Incorporated Skin Substitutes from Biological Sources Product
Table 111. Cook Biotech Incorporated Revenue in Skin Substitutes from Biological Sources Business (2021-2026) & (US$ Million)
Table 112. Cook Biotech Incorporated Recent Development
Table 113. Aroa Biosurgery Company Details
Table 114. Aroa Biosurgery Business Overview
Table 115. Aroa Biosurgery Skin Substitutes from Biological Sources Product
Table 116. Aroa Biosurgery Revenue in Skin Substitutes from Biological Sources Business (2021-2026) & (US$ Million)
Table 117. Aroa Biosurgery Recent Development
Table 118. Surgalign Holdings Company Details
Table 119. Surgalign Holdings Business Overview
Table 120. Surgalign Holdings Skin Substitutes from Biological Sources Product
Table 121. Surgalign Holdings Revenue in Skin Substitutes from Biological Sources Business (2021-2026) & (US$ Million)
Table 122. Surgalign Holdings Recent Development
Table 123. Anika Therapeutics Company Details
Table 124. Anika Therapeutics Business Overview
Table 125. Anika Therapeutics Skin Substitutes from Biological Sources Product
Table 126. Anika Therapeutics Revenue in Skin Substitutes from Biological Sources Business (2021-2026) & (US$ Million)
Table 127. Anika Therapeutics Recent Development
Table 128. Forticell Bioscience Company Details
Table 129. Forticell Bioscience Business Overview
Table 130. Forticell Bioscience Skin Substitutes from Biological Sources Product
Table 131. Forticell Bioscience Revenue in Skin Substitutes from Biological Sources Business (2021-2026) & (US$ Million)
Table 132. Forticell Bioscience Recent Development
Table 133. MLM Biologics Company Details
Table 134. MLM Biologics Business Overview
Table 135. MLM Biologics Skin Substitutes from Biological Sources Product
Table 136. MLM Biologics Revenue in Skin Substitutes from Biological Sources Business (2021-2026) & (US$ Million)
Table 137. MLM Biologics Recent Development
Table 138. Promethean LifeSciences Company Details
Table 139. Promethean LifeSciences Business Overview
Table 140. Promethean LifeSciences Skin Substitutes from Biological Sources Product
Table 141. Promethean LifeSciences Revenue in Skin Substitutes from Biological Sources Business (2021-2026) & (US$ Million)
Table 142. Promethean LifeSciences Recent Development
Table 143. Skin Substitutes from Biological Sources Market Trends
Table 144. Skin Substitutes from Biological Sources Market Drivers
Table 145. Skin Substitutes from Biological Sources Market Challenges
Table 146. Skin Substitutes from Biological Sources Market Restraints
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources

List of Figures
Figure 1. Skin Substitutes from Biological Sources Product Picture
Figure 2. Global Skin Substitutes from Biological Sources Market Share by Type: 2025 vs 2032
Figure 3. Allogeneic Acellular Cells Features
Figure 4. Xenogeneic Cells Features
Figure 5. Allogeneic Cells Features
Figure 6. Autologous Cells Features
Figure 7. Global Skin Substitutes from Biological Sources Market Share by Application: 2025 vs 2032
Figure 8. Hospitals
Figure 9. Specialty Clinics
Figure 10. Wound Care Centers
Figure 11. Skin Substitutes from Biological Sources Report Years Considered
Figure 12. Global Skin Substitutes from Biological Sources Market Size (US$ Million), Year-over-Year: 2021-2032
Figure 13. Global Skin Substitutes from Biological Sources Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Skin Substitutes from Biological Sources Market Share by Revenue, by Region: 2021 vs 2025
Figure 15. North America Skin Substitutes from Biological Sources Revenue (US$ Million) Growth Rate (2021-2032)
Figure 16. Europe Skin Substitutes from Biological Sources Revenue (US$ Million) Growth Rate (2021-2032)
Figure 17. China Skin Substitutes from Biological Sources Revenue (US$ Million) Growth Rate (2021-2032)
Figure 18. Japan Skin Substitutes from Biological Sources Revenue (US$ Million) Growth Rate (2021-2032)
Figure 19. Global Skin Substitutes from Biological Sources Market Share by Players in 2025
Figure 20. Global Top Skin Substitutes from Biological Sources Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Skin Substitutes from Biological Sources as of 2025)
Figure 21. The Top 10 and 5 Players Market Share by Skin Substitutes from Biological Sources Revenue in 2025
Figure 22. North America Skin Substitutes from Biological Sources Market Share by Type (2021-2026)
Figure 23. North America Skin Substitutes from Biological Sources Market Share by Application (2021-2026)
Figure 24. Europe Skin Substitutes from Biological Sources Market Share by Type (2021-2026)
Figure 25. Europe Skin Substitutes from Biological Sources Market Share by Application (2021-2026)
Figure 26. China Skin Substitutes from Biological Sources Market Share by Type (2021-2026)
Figure 27. China Skin Substitutes from Biological Sources Market Share by Application (2021-2026)
Figure 28. Japan Skin Substitutes from Biological Sources Market Share by Type (2021-2026)
Figure 29. Japan Skin Substitutes from Biological Sources Market Share by Application (2021-2026)
Figure 30. Allergan (AbbVie) Revenue Growth Rate in Skin Substitutes from Biological Sources Business (2021-2026)
Figure 31. AlloSource Revenue Growth Rate in Skin Substitutes from Biological Sources Business (2021-2026)
Figure 32. Organogenesis Revenue Growth Rate in Skin Substitutes from Biological Sources Business (2021-2026)
Figure 33. BD Revenue Growth Rate in Skin Substitutes from Biological Sources Business (2021-2026)
Figure 34. Smith & Nephew Revenue Growth Rate in Skin Substitutes from Biological Sources Business (2021-2026)
Figure 35. Integra LifeSciences Revenue Growth Rate in Skin Substitutes from Biological Sources Business (2021-2026)
Figure 36. Synthes (Johnson & Johnson) Revenue Growth Rate in Skin Substitutes from Biological Sources Business (2021-2026)
Figure 37. Axogen Revenue Growth Rate in Skin Substitutes from Biological Sources Business (2021-2026)
Figure 38. Vericel Corporation Revenue Growth Rate in Skin Substitutes from Biological Sources Business (2021-2026)
Figure 39. LifeNet Health Revenue Growth Rate in Skin Substitutes from Biological Sources Business (2021-2026)
Figure 40. MTF Biologics Revenue Growth Rate in Skin Substitutes from Biological Sources Business (2021-2026)
Figure 41. Arthrex Revenue Growth Rate in Skin Substitutes from Biological Sources Business (2021-2026)
Figure 42. Wright Medical Group NV (Stryker) Revenue Growth Rate in Skin Substitutes from Biological Sources Business (2021-2026)
Figure 43. Cook Biotech Incorporated Revenue Growth Rate in Skin Substitutes from Biological Sources Business (2021-2026)
Figure 44. Aroa Biosurgery Revenue Growth Rate in Skin Substitutes from Biological Sources Business (2021-2026)
Figure 45. Surgalign Holdings Revenue Growth Rate in Skin Substitutes from Biological Sources Business (2021-2026)
Figure 46. Anika Therapeutics Revenue Growth Rate in Skin Substitutes from Biological Sources Business (2021-2026)
Figure 47. Forticell Bioscience Revenue Growth Rate in Skin Substitutes from Biological Sources Business (2021-2026)
Figure 48. MLM Biologics Revenue Growth Rate in Skin Substitutes from Biological Sources Business (2021-2026)
Figure 49. Promethean LifeSciences Revenue Growth Rate in Skin Substitutes from Biological Sources Business (2021-2026)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed